Kuroda N, Matsumoto H, Ohe C, Mikami S, Nagashima Y, Inoue K, Perez-Montiel D, Petersson F, Michal M, Hes O, Yang X J
Naoto Kuroda MD, Department of Diagnostic Pathology, Kochi Red Cross Hospital Shin-honmachi 2-13-51, Kochi City, Kochi 780-8562, Japan, tel. +81-88-822-1201, fax +81-88-822-1056, e-mail:
Pol J Pathol. 2013 Dec;64(4):233-7. doi: 10.5114/pjp.2013.39329.
Tubulocystic carcinoma of the kidney (TCK) is a recently established entity in renal neoplastic pathology. This review aims to give an overview of the clinical and pathobiological aspects of TCK. Grossly, the TCKs are well-demarcated multicystic lesions giving a "wrapped bubble" or "spongy" appearance. Microscopically, the tumors are composed of multiple, variably sized cysts separated by thin fibrous septa lacking ovarian stroma or desmoplastic reaction. The cysts are lined by tumor cells with eosinophilic cytoplasm and nuclear atypia of variable, but not infrequently of high grade corresponding to Fuhrman grade 3. A frequent association with papillary tumors has been reported. Recent molecular genetic studies of TCK have revealed distinct features separating this subset of renal cell carcinomas (RCCs) from other types of renal tumors including collecting duct carcinoma of Bellini and renal medullary carcinoma as well as pointing towards a close kinship with papillary RCC. Tubulocystic carcinoma of the kidney generally pursues an indolent clinical course. However, several cases with aggressive clinical behavior have been reported. We strongly feel that there is enough clinicopathological evidence to corroborate TCK as a separate entity and that it should be incorporated into the next WHO classification of renal tumors as a separate neoplastic category.
肾管囊状癌(TCK)是肾肿瘤病理学中最近确立的一种实体。本综述旨在概述TCK的临床和病理生物学方面。大体上,TCK是边界清楚的多囊性病变,呈“包裹的气泡”或“海绵状”外观。显微镜下,肿瘤由多个大小不一的囊肿组成,囊肿之间由薄的纤维间隔分隔,缺乏卵巢间质或促纤维增生性反应。囊肿内衬肿瘤细胞,其细胞质嗜酸性,核异型性各异,但高级别核异型并不少见,相当于福尔曼3级。据报道,TCK常与乳头状肿瘤相关。最近对TCK的分子遗传学研究揭示了将这种肾细胞癌(RCC)亚型与其他类型的肾肿瘤(包括贝氏集合管癌和肾髓质癌)区分开来的独特特征,同时也表明其与乳头状RCC关系密切。肾管囊状癌通常临床病程惰性。然而,已有几例具有侵袭性临床行为的病例报道。我们强烈认为,有足够的临床病理证据证实TCK是一种独立的实体,应作为一个单独的肿瘤类别纳入下一次世界卫生组织肾肿瘤分类中。